Quick10K

⚲

Education Realty Trust

Filings

S-1	2021-06-30	Public Filing
10-Q	2021-03-31	Filed 2021-06-02
S-1	2021-03-31	Public Filing
10-Q	2018-06-30	Filed 2018-08-08
10-Q	2018-03-31	Filed 2018-05-02
10-K	2017-12-31	Filed 2018-02-27
10-Q	2017-09-30	Filed 2017-10-30
10-Q	2017-06-30	Filed 2017-07-31
10-Q	2017-03-31	Filed 2017-05-01
10-K	2016-12-31	Filed 2017-02-28
10-Q	2016-09-30	Filed 2016-10-31
10-Q	2016-06-30	Filed 2016-08-01
10-Q	2016-03-31	Filed 2016-05-02
10-K	2015-12-31	Filed 2016-02-29
10-Q	2015-09-30	Filed 2015-11-02
10-Q	2015-06-30	Filed 2015-08-05
10-Q	2015-03-31	Filed 2015-05-06
10-K	2014-12-31	Filed 2015-02-27
10-Q	2014-09-30	Filed 2014-11-07
10-Q	2014-06-30	Filed 2014-08-06
10-Q	2014-03-31	Filed 2014-05-07
10-K	2013-12-31	Filed 2014-03-03
10-Q	2013-09-30	Filed 2013-11-06
10-Q	2013-06-30	Filed 2013-07-31
10-Q	2013-03-31	Filed 2013-05-07
10-K	2012-12-31	Filed 2013-03-01
10-Q	2012-09-30	Filed 2012-11-06
10-Q	2012-06-30	Filed 2012-08-07
10-Q	2012-03-31	Filed 2012-05-08
10-K	2011-12-31	Filed 2012-03-08
10-Q	2011-09-30	Filed 2011-11-09
10-Q	2011-06-30	Filed 2011-08-08
10-Q	2011-03-31	Filed 2011-05-09
10-K	2010-12-31	Filed 2011-03-09
10-Q	2010-09-30	Filed 2010-11-05
10-Q	2010-06-30	Filed 2010-08-06
10-Q	2010-03-31	Filed 2010-05-07
10-K	2009-12-31	Filed 2010-03-16

Reports

8-K	2018-09-20
8-K	2018-09-14
8-K	2018-08-21
8-K	2018-08-09
8-K	2018-06-25
8-K	2018-05-10
8-K	2018-04-30
8-K	2018-03-05
8-K	2018-02-22
8-K	2018-02-20
8-K	2018-02-20
8-K	2018-01-04

Education Realty Trust Financials

EDR Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin


Comps ($MM TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)


Balance Sheet ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30
Cash	71	47	76	21	8	128	15	11	16	22	29	14	18	18	24	17	14	34	196	230	115	34	35	33	47	29	27	18
Accounts Receivable	0	0	0	0	0	0	1	1	2	1	1	1	2	2				3				4				6
Inventory
PP&E								3	3	1,506	3	3	3	1,707				1,892				2,399				2,913
Assets	783	826	978	973	1,000	1,170	1,357	1,397	1,544	1,611	1,630	1,666	1,813	1,812	1,852	1,889	1,976	2,002	2,197	2,466	2,483	2,506	2,720	2,803	2,926	3,015	3,064	3,335
Accounts Payable
Long-Term Debt	330	336	359	334	311	323	421	436	435	423	390	361	336	687	668	662	671	643	557	537	500	520	727	812	811	936	980	997
Liabilities	362	378	405	384	399	391	586	623	794	871	893	713	829	805	846	895	1,006	743	666	659	653	666	885	985	1,022	1,116	1,152	1,164
Stockholders' Equity	412	437	562	578	589	764	757	760	736	726	724	940	969	989	988	977	952	1,237	1,512	1,782	1,806	1,800	1,788	1,766	1,847	1,845	1,856	2,076


Income Statement ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30
Revenue	29	30	36	38	36	35	47	53	44	55	55	60	55	67	64	57	58	76	73	65	66	84	86	74	75	96	91	76
Cost of Revenue																								3	5	3	3	3
Gross Profit																								71	70	93	88	73
R&D
SG&A	3	3	3	2	2	2	2	2	2	2	2	2	3	3	3	3	1	3	3	3	3	3	3	3	3	5	3	9
Tax	-0	0	0	0	0	0	0	0	0	0	0	-0	1	-0	0	0	0	0	0	0	0	0	0	0	0	2	0	0
Net Income	1	-6	-6	2	10	0	3	7	-4	2	12	8	21	23	7	3	-5	15	17	18	-4	14	16	6	-0	25	41	63


Cash Flow ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-03-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30
Cash Operating		11	15	13	17	13	20	18	26	14	17	19	35	18	29	17	21	34	38	23	39	33	46	24	52	31	31	36
Cash Investing		-71	-140	-57	-44	-50	-56	-47	-158	-37	-32	-61	-153	10	-48	-65	-97	-36	-38	-223	-142	-123	-228	-85	-121	-137	-42	-108
Cash Financing		36	153	-10	14	156	33	26	137	29	2	44	126	-28	24	42	74	22	163	235	-13	9	183	60	84	80	9	63